ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,304Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 278

$795K Total Retail Price of All Prescriptions

Rank: 49 out of 278

294 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 294 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,813 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 524 438 1 4
LEVOTHYROXINE SODIUM 509 460 2 2
METOPROLOL TARTRATE 391 329 3 9
FUROSEMIDE 349 299 4 6
LISINOPRIL 346 295 5 5
OMEPRAZOLE 323 301 6 3
HYDROCODONE-ACETAMINOPHEN 308 140 S3 7 1
METOPROLOL SUCCINATE 241 209 8 10
GABAPENTIN 240 185 9 12
HYDROCHLOROTHIAZIDE 235 199 10 15
WARFARIN SODIUM 214 188 11 11
CARVEDILOL 206 195 12 23
CLOPIDOGREL 201 171 13 20
BUMETANIDE 183 178 14 154
TRAMADOL HCL 182 149 15 22
METFORMIN HCL 173 134 16 8
DONEPEZIL HCL 168 168 17 29
TAMSULOSIN HCL 166 161 18 32
AMLODIPINE BESYLATE 163 147 19 7
POTASSIUM CHLORIDE 162 136 20 17
SPIRIVA 153 105 21 49
NAMENDA 153 153 21 48
PLAVIX 152 129 23 30
ADVAIR DISKUS 147 110 24 45
NEXIUM 145 81 25 14
OXYCODONE-ACETAMINOPHEN 138 132 S2 26 71
MIRTAZAPINE 137 137 27 61
HYDRALAZINE HCL 117 91 28 91
GLIMEPIRIDE 117 100 28 28
NIASPAN 116 103 30 119
AZITHROMYCIN 116 102 30 39
PRAVASTATIN SODIUM 108 100 32 16
LANTUS 107 78 33 56
PANTOPRAZOLE SODIUM 102 71 34 36
JANUVIA 98 82 35 53
BACLOFEN 97 80 36 172
OXYCODONE HCL-ACETAMINOPHEN 96 46 S2 37 83
FAMOTIDINE 95 80 38 116
PHENYTOIN SODIUM EXTENDED 94 81 39 135
PROAIR HFA 93 51 40 34
SINGULAIR 92 83 41 60
RISPERIDONE 87 72 42 79
CIPROFLOXACIN HCL 86 69 43 65
ALBUTEROL SULFATE 85 39 44 141
ALLOPURINOL 84 81 45 38
LEVETIRACETAM 80 40 46 106
LOSARTAN POTASSIUM 79 59 47 24
CYMBALTA 79 69 47 41
ATENOLOL 79 75 47 18
DIGOXIN 78 78 50 40
FENTANYL 78 76 S2 50 82
FLUTICASONE PROPIONATE 73 65 52 44
DOXYCYCLINE HYCLATE 71 63 53 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 58 54 31
NITROGLYCERIN PATCH 67 67 55 125
MELOXICAM 67 67 55 37
LACTULOSE 67 41 55 155
PAROXETINE HCL 67 66 55 57
RANITIDINE HCL 66 56 59 27
ZOLPIDEM TARTRATE 64 48 60 26
SERTRALINE HCL 64 55 60 25
ATORVASTATIN CALCIUM 63 59 62 13
TRAZODONE HCL 62 46 63 47
OXYBUTYNIN CHLORIDE ER 60 53 64 146
ALENDRONATE SODIUM 60 60 64 51
MONTELUKAST SODIUM 60 42 64 96
FLUOXETINE HCL 60 58 64 68
PREDNISONE 60 59 64 35
LOSARTAN-HYDROCHLOROTHIAZIDE 58 58 69 54
TRICOR 58 39 69 87
NYSTATIN 56 49 71 218
CLONIDINE HCL 56 31 71 50
FINASTERIDE 55 48 73 104
BUSPIRONE HCL 55 44 73 178
ENOXAPARIN SODIUM 53 0 75 343
ESCITALOPRAM OXALATE 53 33 75 63
ISOSORBIDE MONONITRATE ER 52 52 77 33
CARBIDOPA-LEVODOPA 51 41 78 113
ENDOCET 50 33 S2 79 210
VERAPAMIL ER 50 34 79 120
VITAMIN D2 50 44 79 168
KLOR-CON M20 50 50 79 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.